Analyst Reco. Savara Inc.

Equities

SVRA

US8051111016

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-03 pm EDT			5-day change	1st Jan Change
4.705 ^USD	+0.53%		+6.69%	+0.11%

Apr. 12	Dr. Ricky Sun Notifies the Board of Directors of Savara Inc. of His Intention Not to Stand for Reelection	CI
Apr. 08	Savara to Present New Data on Autoimmune Pulmonary Alveolar Proteinosis at the American Thoracic Society International Conference 2024	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Piper Sandler Adjusts Price Target on Savara to $16 From $7, Maintains Overweight Rating	Mar. 04	MT
JMP Securities Starts Savara With Market Outperform Rating, $8 Price Target	Feb. 15	MT
Guggenheim Starts Savara With Buy Rating, $7 Price Target	Nov. 07	MT
HC Wainwright Adjusts Price Target on Savara to $6 From $3, Keeps Buy Rating	23-08-14	MT
Jefferies Downgrades Savara to Hold From Buy With $2 Price Target	23-04-03	MT
History shows stocks can weather rate hike cycle	22-03-16	RE
SAVARA : Piper Sandler Starts Savara at Overweight With $7 Price Target	21-03-16	MT
SAVARA : Oppenheimer Initiates Savara at Outperform With $4 Price Target	21-03-15	MT
SAVARA : HC Wainwright Adjusts Savara's Price Target to $3 From $6, Keeps at Buy	20-12-15	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer